https://adisinsight.springer.com/drugs/800086774?error=cookies_not_supported&code=2935ba07-8a4f-4c09-b125-1cc9b56e66ef
GSK 5533524 - AdisInsight
GSK 5533524 is an intravenously administered therapeutic being developed by GlaxoSmithKline for the treatment of solid tumours. Clinical development is underway
gskadisinsight